Clinical trial Recruiting at 1 site Interventional Ages 18 and up

First Breath: a digital program to reduce prenatal secondhand smoke exposure

Official title: Feasibility and Acceptability of a Digital Intervention Program Aiming to Reduce Secondhand Smoke Exposure in Pregnancy: a Pilot Study

Run by Hebrew University of Jerusalem · NCT07003282 · Data updated 2026-11-12

This pilot tests the First Breath app with pregnant women and their smoking partners to help reduce secondhand smoke exposure at home and in the car.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorHebrew University of Jerusalem
Academic / other
Locations1 site (Jerusalem)
StatusRecruiting
StartedMarch 30, 2025
Main results expectedOctober 30, 2025
Study endsDecember 1, 2025
Registry record updatedSeptember 12, 2025
Trial IDNCT07003282 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant, non-smoking women ≤24 weeks gestation who live with an adult partner who smokes daily and both can read Hebrew and access the internet.

Probably not a fit

Women with high-risk pregnancies, those without internet access, or couples whose smoking partner is already enrolled in a cessation program are unlikely to receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot enrolls pregnant women up to 24 weeks who do not smoke and their smoking partners to test a digital behavioral program called First Breath. Participants use the app, receive follow-up reminders, and pregnant women receive personal urine cotinine results as biochemical feedback. The program combines education on health risks, stepwise strategies to avoid exposure in the home and car, motivation-building, and advice about using nicotine-replacement therapy in the household. Feasibility and acceptability outcomes will be collected during follow-up to refine the intervention for larger trials.

Why it matters

Potential benefit: If successful, it could lower pregnant women's exposure to secondhand smoke and reduce related risks to fetal and maternal health.

How similar studies have gone: Similar partner-inclusive digital interventions and biomarker feedback approaches have shown promising results in reducing household secondhand smoke, but evidence specifically in prenatal populations remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Pregnant women:

Inclusion criteria:

1. ≤24 gestational weeks;
2. at least 18 years old;
3. living with a partner who smokes (at least one combustible cigarette a day); d) ability to understand Hebrew at a reasonable level;

e) currently not smoking any tobacco or nicotine product (to clarify, women who smoked in the past are eligible).

Exclusion criteria:

1. women with high-risk pregnancies,
2. no access to internet,
3. her partner is currently involved in a smoking cessation process.

Expectant fathers who smoke:

Inclusion criteria:

1. male,
2. at least 18 years old,
3. able to understand Hebrew at a reasonable level,
4. smoking at least one combustible cigarette per day,
5. currently living with a pregnant spouse who does not smoke any tobacco or nicotine product and
6. the spouse is ≤24 gestational weeks . Note: expectant father who are current users of other tobacco products (such as electronic cigarettes) are also eligible as long as they smoke at least one combustible cigarette a day.

Exclusion criteria:

1. currently engaged in a smoking cessation program,
2. no access to the internet.

Where it's running

  • Braun School of Public Health and Community Medicine, Hebrew University of Jerusalem
    Jerusalem, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.